___

• Kaynaklar 1.Gasparani R. Clinical and socioeconomic impact of seasonaland pandemik influenza in adults and elderly. Human vacci-nes and Immunotherapeutics 2012; 8: 21-28. 2.Neuzil KM, Hohbein C, Zhu Y. Illness among school childrenduring influenza season. Effect on school absteeism, paren-tal absteeism form work and secondary illness in families. ArchPediatr Adolesc Med 2002: 156: 986-91. 3.Cohen JM, Errieau G. Ouvrage collectif dirige par le docte-urs. Gribin Tuzakları. Çev Ed: Selim Badur. Genişletilmiş 2.Baskı. Bil-medya grup-Merajans Ltd Şti, İstanbul, 2012. 4.World Health Organisation. İnfluenza virus infections in hu-mans. (February 2014). http://www.who.int/influenza/hu-man_ animal_interface/virology_laboratories_and_vaccines/in-fluenza_virus_infections_humans_feb14.pdf?ua=1 5.Cowling BJ, Chan KH, Fang VJ, et al. Comparative epidemio-logy of pandemic and seasonal influenza A in households. NEngl J Med 2010; 362: 2175-84, DOI: 10.1056/NEJ-Moa0911530 6.Mughini-Gras L, Pijnacker R, Enserink R, Heusinkveld M, vander Hoek W, van Pelt W. Influenza-like illness in households withchildren of preschool age. Pediatr Infect Dis J 2016; 35: 242-48. 7.Treanor JT. Influenza viruses, including Avian influenza andswine influenza. In: Mandell GL, Bennett JE, Dolin R, eds. Prin-ciples and Practice of Infectious Diseases,7th ed. Philadelp-hia: Churchill Livingstone, 2010: 2274. 8.World Health Organisation. Influenza virus infections in hu-mans. (February 2014). http://www.who.int/influenza/human_animal_interface/virology_laboratories_and_vaccines/influenza_virus_infections_humans_feb14.pdf?ua=1 9.Carrat F, Vergu E, Ferguson NM, et al. Time lines of infec-tion and disease in human influenza: a review of volunteer chal-lenge studies. Am J Epidemiol 2008; 167: 775–85. 10.Centers for Disease Control and Prevention (CDC). Clinicalsigns and symptoms of influenza. http://www.cdc.gov/flu/pro-fessionals/diagnosis/index.htm 02.06.2014 tarihinde erişildi 11.Punpanich W, Chotpitayasunondh T. A review on the clinicalspectrum and natural history of human influenza. Int J InfectDis 2012; 16: e714-23. doi: 10.1016/j.ijid.2012.05.1025. 12.WHO. Influenza Vaccine use. http://www.who.int/influenza/vac-cines/use/en/. 13.van Zwol A, Witteveen R, Markhorst D, Geukers VG. Clini-cal features of a Dutch cohort of critically ill children due tothe 2009 new influenza A H1N1 pandemic. Clin Pediatr (Phi-la) 2011; 50: 69–72. 14.Bagdure D, Curtis DJ, Dobyns E, Glode MP, Dominguez SR.Hospitalized children with 2009 pandemic influenza A(H1N1): comparison to seasonal influenza and risk factors foradmission to the ICU. PLoS One 2010; 5: e15173. 15.Wong KK, Jain S, Blanton L, et al. Influenza associated pe-diatric deaths in the United States 2004-2012. Pediatrics 2013;132: 769-804. 16.Chaves SS, Aragon D, Bennett N. The burden of influenza hos-pitalizations in infants from 2003 to 2012, United States. Pe-diatr Infect Dis J 2014; 33: 912-19. 17.Short KR, Reading PC, Brown LE, et al. Influenza-induced in-flammation drives pneumococcal otitis media. Infect Immun 2013;81: 645-52. doi: 10.1128/IAI.01278-12. Epub 2013 Jan 14. 18.Herold S, Becker C, Ridge KM, Budinger GR. Influenza vi-rus-induced lung injury: pathogenesis and implications for tre-atment. Eur Respir J 2015; 45: 1463-78. doi: 10.1183/09031936.00186214. Epub 2015 Mar 18. 19.Stockmann C, Ampofo K, Hersh AL, et al. Seasonality of acu-te otitis media and the role of respiratory viral activity in child-ren. Pediatr Infect Dis J 2013; 32: 314-19. doi: 10.1097/ INF.0b013e31827d104e. 20.Ambrose CS, Antonova EN. The healthcare and societal bur-den associated with influenza in vaccinated and unvaccina-ted European and Israeli children. Eur J Clin Microbiol In-fect Dis 2014; 33: 569-75. doi: 10.1007/s10096-013-1986-6.Epub 2013 Oct 4. 21.Chonmaitree T, Alvarez-Fernandez P, Jennings K, et al.Symptomatic and asymptomatic respiratory viral infections inthe first year of life: association with acute otitis media de-velopment. Clin Infect Dis 2015; 60: 1-9. doi:10.1093/cid/ciu714. Epub 2014 Sep 9. 22.Guan WD, Gong XY, Mok CK, et al. Surveillance for seaso-nal influenza virus prevalence in hospitalized children withlower respiratory tract infection in Guangzhou, China duringthe post-pandemic era. PLoS One 2015; 10: e0120983. doi:10.1371/journal.pone.0120983. eCollection 2015. 23.Haas J, Braun S, Wutzler P. Burden of influenza in Germany:a retrospective claims database analysis for the influenza sea-son 2012/2013. Eur J Health Econ 2016; 17: 669-79. 24.Kwon JM, Shim JW, Kim DS, et al. Prevalence of respiratoryviral infection in children hospitalized for acute lower respi-ratory tract diseases, and association of rhinovirus and influ-enza virus with asthma exacerbations. Korean J Pediatr 2014;57: 29-34. doi: 10.3345/kjp.2014.57.1.29. Epub 2014 Jan 31. 25.Kitcharoen S, Pattapongsin M, Sawanyawisuth K, Angela V,Tiamkao S. Neurologic manifestations of pandemic (H1N1)2009 virus infection. Emerg Infect Dis 2010; 16: 569–70. 26.Calderaro D, dos Santos S, Tonacio AC, et al. Acute myocar-ditis in H1N1 influenza A virus infection. Rev Assoc Med Bras2010; 56:394. 27.World Health Organisation. Influenza: Patient care.http://www.who.int/influenza/patient_care/en/ 29 Mayıs 2014tarihinde erişildi.28.Micheilis B. Clinical prediction rules combining signs,symptoms and epidemiological context to distinguish influen-za from influenza-like illnesses in primary care: a cross sec-tional study. BMC Fam Pract 2011; 12: 4. doi: 10.1186/1471-2296-12-4 29.Gren LH. Point-of-Care Testing as an Influenza Surveillan-ce Tool: Methodology and Lessons Learned from Implemen-tation. Influenza Research and Treatment Volume 2013, Ar-ticle ID 242970, 10 page http://dx.doi.org/10.1155/2013/242970 30.Tanei M, Yokokawa H, Murai K, et al. Factors influencing thediagnostic accuracy of the rapid influenza antigen detectiontest (RIADT): a cross-sectional study. BMJ Open 2014; 4:e003885. doi: 10.1136/bmjopen-2013-003885 31.Nitsch-Osuch A. Influence of rapid influenza test on clinicalmanagement of children younger than five with febrile respi-ratory tract infections. Adv Exp Med Biol 2013; 755: 237-41. 32.Vasquez RD, Chavez VM, Gamio IE, et al. Probable verticaltransmission of the influenza virus A (H1N1): apropos of a case.Rev Peru Med Exp Salud Publica 2010; 27: 466–69. 33.Manzoli l, Schioppa F, Bocci A, Villari P. The efficacy of in-fluenza vaccine for healthy children: a meta-analysis evalua-ting potential sources of variation in efficacy estimates inclu-ding study quality. Pediatr Infect Dis J 2007; 26: 97-106. 34.Heiononen S, Silvennoinen H, Lehtinen P, et al. Effectivenessof inactivated influenza vaccine in children aged 9 months to3 years: an observational cohort study. Lancet Infect Dis 2011;11: 23-29. 35.Blyth CC, Jacoby P, Effler PV, et al, and WAIVE Study Team.Influenza vaccine effectiveness and uptake in children at riskof severe disease. Pediatr Infect Dis J 2016; 35: 309-15. 36-Ohmit SE, Petrie JG, Malosh RE, et al. Influenza vaccine ef-fectiveness in households with children during the 2013-2014influenza season, when 2009 pandemic influenza A (H1N1)virus predominated. J Infect Dis 2015; 2 (Suppl 1): pii: jiv563. 37-Belse BB, Edwards KM, Vesikari T, et al. Live attenuated ver-sus inactivated influenza vaccine in infants and young child-ren. N Eng J Med 2007; 356: 385-96. 38.Centers for Diseases Control and Prevention (CDC). Preven-ting Seasonal Flu With Vaccination. http://www.cdc.gov/flu/protect/vaccine/index.htm 39.Yang HJ. Safety of influenza vaccination in children with al-lergic diseases. Clin Exp Vaccine Res 2015; 4: 137-44. doi:10.7774/cevr.2015.4.2.137. Epub 2015 Jul 29. 40.Rusmil K, Gunardi H, Fadlyana E, et al. The immunogenicity, sa-fety, and consistency of an Indonesia combined DTP-HB-Hib vac-cine in expanded program on immunization schedule. BMC Pe-diatr 2015; 15: 219. doi: 10.1186/s12887-015-0525-2. 41.Jefferson T, Del Mar CB, Dooley L, et al. Physical interven-tions to interrupt or reduce the spread of respiratory viruses.Cochrane Database Syst Rev. 2011 Jul 6;(7):CD006207 42.Zayas G, Chiang MC, Wong E, et al. Effectiveness of coughetiquette maneuvers in disrupting the chain of transmissionof infectious respiratory diseases. BMC Public Health 2013;13: 811. doi:10.1186/1471-2458-13-811 43.Golovyan DM, Mosad SF. Prevention and treatment of influ-enza in the primary care Office. Cleveland Clin J Med 2014;81: 189-99. 44.American Academy of Pediatrics Committee on Infectious Di-seases. American Academy of Pediatrics Committee on Infec-tious Diseases. Pediatrics 2008; 121 (4): e1016-31. doi:10.1542/peds.2008-0160.